The Resource Primary care management of abnormal uterine bleeding, prepared for Agency for Healthcare Research and Quality ; prepared by Vanderbilt Evidence-based Practice Center ; investigators, Katherine E. Hartmann, Rebecca N. Jerome, Mary-Louise Lindegren, Shannon A. Potter, Tracy C. Shields, Tanya S. Surawicz, Jeffrey C. Andrews

Primary care management of abnormal uterine bleeding, prepared for Agency for Healthcare Research and Quality ; prepared by Vanderbilt Evidence-based Practice Center ; investigators, Katherine E. Hartmann, Rebecca N. Jerome, Mary-Louise Lindegren, Shannon A. Potter, Tracy C. Shields, Tanya S. Surawicz, Jeffrey C. Andrews

Label
Primary care management of abnormal uterine bleeding
Title
Primary care management of abnormal uterine bleeding
Statement of responsibility
prepared for Agency for Healthcare Research and Quality ; prepared by Vanderbilt Evidence-based Practice Center ; investigators, Katherine E. Hartmann, Rebecca N. Jerome, Mary-Louise Lindegren, Shannon A. Potter, Tracy C. Shields, Tanya S. Surawicz, Jeffrey C. Andrews
Title variation
Effective health care program
Creator
Contributor
Author
Subject
Genre
Language
eng
Summary
Objective: The Vanderbilt Evidence-based practice Center systematically reviewed evidence about interventions for symptomatic abnormal uterine bleeding (AUB), both irregular and cyclic. We focused on interventions that are suitable for use in primary care practice including medical, behavioral, and complementary and alternative medicine approaches. Data sources: We searched MEDLINE, CINAHL, and Embase for randomized controlled trials (RCTs) published in English from January 1980 to June 2012 in women with symptomatic AUB. We also searched regulatory data and scientific publications for data about harms. Review methods: Using dual review with a priori criteria, we excluded 1,734 publications because they did not address a Key Question, were not an eligible study design, or did not apply to the primary care treatment of AUB. Results: Thirty-nine RCTs (6 good quality, 10 fair quality, and 23 poor quality) evaluated 12 distinct interventions. These included 7 studies of the levonorgestrel-releasing intrauterine system (LNG-IUS), 13 of nonsteroidal anti-inflammatory drugs (NSAIDs), 6 of tranexamic acid (TXA), and 5 of combined oral contraceptive pills (COCs). The majority of studies made direct comparisons to other drugs. Ten studies enrolled women with irregular uterine bleeding; the remainder focused on women with heavy cyclic bleeding. Among women with irregular menses, metformin, metformin with exenatide, and a tricyclic oral contraceptive improved menstrual regularity. Among women with heavy, cyclic menstrual bleeding all seven studies of LNG-IUS favored the intrauterine system in comparisons that included NSAIDs, COCs, progestogens and usual care. Reduction in menstrual blood loss ranged from 70 to 87 percent less bleeding than baseline. NSAIDs reduced bleeding in six of six studies when compared with placebo or progestogens. The degree of improvement was highly variable for individual women. TXA was more effective than progestogens and NSAIDs in three of four studies, and COCs provided benefit compared with placebo in two studies. Harms were rare and trials underpowered to assess harms for all interventions. For most interventions, surveillance studies of longer-term risks were not done in comparable populations. Conclusions: Two interventions for irregular bleeding (metformin, COCs) and four for heavy cyclic bleeding (LNG-IUS, NSAIDs, TXA) have low or moderate strength of evidence for effectiveness, while COCs have high strength of evidence. Several common interventions (including diet and exercise and acupuncture) lack sufficient evidence. Across interventions, data are sparse to evaluate long-term improvements and risk of harms. Limitations include a predominance of small, short trials lacking standard terminology and diagnostic criteria for identifying and including women with AUB. Tools for collecting outcome data are crude (e.g., collection of sanitary products to measure blood loss) and may contribute to a high rate of attrition. Emphasis on biologic outcomes may neglect the importance of patient-reported outcomes that assess whether symptoms are considered resolved by women themselves
Member of
Cataloging source
MMU
http://library.link/vocab/creatorName
Hartmann, Katherine E
Funding information
Conducted by the Vanderbilt Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality (AHRQ)
Government publication
federal national government publication
Illustrations
illustrations
Index
no index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
NLM call number
WP 555
http://library.link/vocab/relatedWorkOrContributorName
  • Jerome, Rebecca N.
  • Lindegren, Mary Louise
  • Potter, Shannon A.
  • Shields, Tracy C.
  • Surawicz, Tanya S.
  • Andrews, Jeff
  • Vanderbilt Evidence-based Practice Center
  • United States
  • Effective Health Care Program (U.S.)
Series statement
  • Comparative effectiveness review
  • AHRQ publication,
Series volume
  • no. 96
  • no. 13-EHC025-EF
http://library.link/vocab/subjectName
  • Metorrhagia
  • Anti-Inflammatory Agents, Non-Steroidal
  • Comparative Effectiveness Research
  • Contraceptives, Oral, Combined
  • Intrauterine Devices, Medicated
  • Primary Health Care
  • Tranexamic Acid
  • United States
  • United States
http://bibfra.me/vocab/relation/supportingbody
RzTDSdffmEM
Label
Primary care management of abnormal uterine bleeding, prepared for Agency for Healthcare Research and Quality ; prepared by Vanderbilt Evidence-based Practice Center ; investigators, Katherine E. Hartmann, Rebecca N. Jerome, Mary-Louise Lindegren, Shannon A. Potter, Tracy C. Shields, Tanya S. Surawicz, Jeffrey C. Andrews
Instantiates
Publication
Note
"March 2013."
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier.
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent.
Control code
841174413
Extent
1 online resource (528 pages)
Form of item
online
Media category
computer
Media MARC source
rdamedia.
Media type code
  • c
Other physical details
illustrations.
Specific material designation
remote
System control number
(OCoLC)841174413
Label
Primary care management of abnormal uterine bleeding, prepared for Agency for Healthcare Research and Quality ; prepared by Vanderbilt Evidence-based Practice Center ; investigators, Katherine E. Hartmann, Rebecca N. Jerome, Mary-Louise Lindegren, Shannon A. Potter, Tracy C. Shields, Tanya S. Surawicz, Jeffrey C. Andrews
Publication
Note
"March 2013."
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier.
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent.
Control code
841174413
Extent
1 online resource (528 pages)
Form of item
online
Media category
computer
Media MARC source
rdamedia.
Media type code
  • c
Other physical details
illustrations.
Specific material designation
remote
System control number
(OCoLC)841174413

Library Locations

  • St. Louis Mercantile LibraryBorrow it
    1 University Blvd, St. Louis, MO, 63121, US
    38.710138 -90.311107
  • Thomas Jefferson LibraryBorrow it
    1 University Blvd, St. Louis, MO, 63121, US
    38.710138 -90.311107
  • University ArchivesBorrow it
    703 Lewis Hall, Columbia, MO, 65211, US
  • University of Missouri-St. Louis Libraries DepositoryBorrow it
    2908 Lemone Blvd, Columbia, MO, 65201, US
    38.919360 -92.291620
  • University of Missouri-St. Louis Libraries DepositoryBorrow it
    2908 Lemone Blvd, Columbia, MO, 65201, US
    38.919360 -92.291620
  • Ward E Barnes Education LibraryBorrow it
    8001 Natural Bridge Rd, St. Louis, MO, 63121, US
    38.707079 -90.311355
Processing Feedback ...